{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:43:31Z","timestamp":1790239411247,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/fpc.0b013e32835c3b24","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T21:16:16Z","timestamp":1354742176000},"page":"53-61","source":"Crossref","is-referenced-by-count":100,"title":["Polymorphisms in the methotrexate transport pathway"],"prefix":"10.1097","volume":"23","author":[{"given":"Elixabet","family":"Lopez-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Pi\u00f1an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Sanchez de Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagore","family":"Garcia de Andoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purificacion","family":"Garcia-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Navajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Africa","family":"Garcia-Orad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2009.07898.x","article-title":"Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia.","volume":"148","author":"Koppen","year":"2010","journal-title":"Br J Haematol"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.canep.2010.06.020","article-title":"Childhood cancer survival: a report from the United Kingdom Childhood Cancer Study.","volume":"34","author":"Johnston","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukemia.","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10038-006-0096-z","article-title":"Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.","volume":"52","author":"Imanishi","year":"2007","journal-title":"J Hum Genet"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2009.008326","article-title":"Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.","volume":"94","author":"Ongaro","year":"2009","journal-title":"Haematologica"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1182\/blood-2006-10-054528","article-title":"Ancestry and pharmacogenetics of antileukemic drug toxicity.","volume":"109","author":"Kishi","year":"2007","journal-title":"Blood"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPH.0b013e318165b25d","article-title":"Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.","volume":"30","author":"Shimasaki","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/gtmb.2010.0083","article-title":"The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia.","volume":"15","author":"Karathanasis","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/leu.2008.66","article-title":"Polymorphisms in folate related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.","volume":"22","author":"Huang","year":"2008","journal-title":"Leukemia"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MBC.0b013e32833135e9","article-title":"Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.","volume":"21","author":"Tantawy","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/10428190902893819","article-title":"Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.","volume":"50","author":"Kantar","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.tpj.6500332","article-title":"Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis.","volume":"5","author":"Krajinovic","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R13-2-20210213","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3109\/10428194.2011.563883","article-title":"Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population.","volume":"52","author":"Liu","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00228-011-1046-z","article-title":"Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.","volume":"67","author":"Faganel Kotnik","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.tpj.6500480","article-title":"Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.","volume":"8","author":"Erdilyi","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pbc.23074","article-title":"Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia.","volume":"57","author":"Lopez-Lopez","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","article-title":"Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.","volume":"27","author":"Trevino","year":"2009","journal-title":"J Clin Oncol"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome.","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"R21-2-20210213","first-page":"1575","article-title":"Frequent somatic demethylation of RAPGEF1C3G intronic sequences in gastrointestinal and gynecological cancer.","volume":"38","author":"Samuelsson","year":"2011","journal-title":"Int J Oncol"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/jhg.2009.79","article-title":"Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients.","volume":"54","author":"Low","year":"2009","journal-title":"J Hum Genet"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-07-6790","article-title":"Transporter-mediated protection against thiopurine-induced hematopoietic toxicity.","volume":"68","author":"Krishnamurthy","year":"2008","journal-title":"Cancer Res"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2008-11-191098","article-title":"Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.","volume":"114","author":"Ansari","year":"2009","journal-title":"Blood"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1124\/jpet.108.136523","article-title":"The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene.","volume":"325","author":"Abla","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10555-007-9039-1","article-title":"Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice.","volume":"26","author":"Kruh","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/jnci\/92.23.1934","article-title":"Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells.","volume":"92","author":"Lee","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R29-2-20210213","first-page":"3144","article-title":"Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/FPC.0b013e3283398a71","article-title":"Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate.","volume":"20","author":"Stamp","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2006.08.012","article-title":"High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.","volume":"80","author":"Rau","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FPC.0b013e328336eee4","article-title":"ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.","volume":"20","author":"Lubomirov","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.healun.2009.11.602","article-title":"Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.","volume":"29","author":"Ohmann","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.fpc.0000236337.41799.b3","article-title":"MRP2 haplotypes confer differential susceptibility to toxic liver injury.","volume":"17","author":"Choi","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2007.12.003","article-title":"Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer.","volume":"63","author":"Han","year":"2009","journal-title":"Lung Cancer"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2007.08.015","article-title":"Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy.","volume":"48","author":"Sookoian","year":"2008","journal-title":"J Hepatol"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.lungcan.2010.09.001","article-title":"Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.","volume":"72","author":"Han","year":"2011","journal-title":"Lung Cancer"},{"key":"R40-2-20210213","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2).","volume":"453","author":"Nies","year":"2007","journal-title":"Pflugers Arch"},{"key":"R41-2-20210213","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.102.035014","article-title":"Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition.","volume":"302","author":"Gerk","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-201302000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T19:31:27Z","timestamp":1714678287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201302000-00002"}},"subtitle":["a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia"],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32835c3b24","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}